ATAI vs COMP
ATAI: A clinical-stage biotechnology company dedicated to developing innovative mental health therapies through a diverse pipeline of neuropsychiatric treatments. COMP: Global real estate services platform combining owned-brokerage brands (Compass, Coldwell Banker, Corcoran, Sotheby's International Realty) with a large franchise network, leveraging proprietary technology and AI to streamline transactions and connect real estate professionals.
Side-by-side fundamentals
| Metric | ATAI | COMP | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $7.18 | $11.26 | |
| Market cap as of 2026-07-23 | $2.7B | $8.5B | |
| P/E as of 2026-07-23 | n/a | 600.49 | |
| Net margin as of 2026-07-23 | -19019.4% | +0.2% | COMP higher |
| Gross margin as of 2026-07-23 | n/a | +20.8% | |
| Operating margin as of 2026-07-23 | -18569.1% | -4.3% | COMP higher |
| ROE as of 2026-07-23 | -366.5% | +1.1% | COMP higher |
| ROA as of 2026-07-23 | -269.0% | +0.4% | COMP higher |
| Debt / equity as of 2026-07-23 | 0.00 | 1.17 | ATAI lower |
| Revenue growth (YoY) as of 2026-07-23 | +86.7% | +40.1% | ATAI higher |
| Revenue CAGR (3y) SEC XBRL | n/a | +5.0% | |
| Beta as of 2026-07-23 | 1.60 | 2.37 | |
| 1-year return as of 2026-07-22 close | +102.1% | +54.2% | ATAI higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.